Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)

Impact Of Sacral Neuromodulation On Urine Markers For IC

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00704457

Enrollment

Registered

2008-06-25

Start date

2004-02-29

Completion date

2007-12-31

Last updated

2013-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Cystitis

Keywords

Interstitial Cystitis, IC, Sacral Nerve Stimulation

Brief summary

Urine will be collected and sent to the University of Maryland. Urines will be analyzed for urine markers.

Detailed description

Urine will be collected and flash frozen in liquid nitrogen then placed in a -70 C freezer. All urine will be collected and stored until the final follow-up is complete. The urine samples will then be sent as a single batch to the Department of Infectious Disease, University of Maryland. Urines will be assayed in a blinded fashion and a written report of the levels of each of the 3 urine markers will be sent to Beaumont Hospital. Change in urine marker levels will be analyzed and correlated with change in symptom scores.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients will be drawn from Dr. Peters patient base that covers Southeast Michigan.

Exclusion criteria

* Male

Design outcomes

Primary

Measure	Time frame
The purpose of this study is measure urine biomarkers levels in patients with interstitial cystitis who have elected to undergo sacral nerve stimulation as a treatment modality for their disease.	1 year

Countries

United States

Outcome results